Antineoplastic activity of the combination of 5-fluorouracil and interferon: preclinical and clinical results.
Interferon (IFN) is capable of modulating the cytotoxic effects and clinical activity of the fluorinated pyrimidine, 5-fluorouracil (5-FU). This occurs in the absence of a demonstrable effect on immune function, suggesting that these effects occur at the biochemical level. Pharmacokinetic studies have also demonstrated that IFN can increase serum levels of 5-FU. The relative importance of these effects on enhancement of 5-FU activity remains to be investigated.